InvestoGain

Investogain Pty Limited
AFS Licence No. 334036

All correspondence to:
admin@delisted.com.au
or by mail to:
PO Box 400
Crows Nest NSW 1585

26 April 2025

Name:	CHEMGENEX PHARMACEUTICALS LTD (CXS)
Date of Listing:	10 July 1986
Date of Delisting:	22 July 2011
Former Names:

Stock Exchange Status: (updated daily)

This entity was delisted from the Australian Securities Exchange on 22 July 2011.

Legal Status: (updated monthly)

To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. We have not therefore verified the current legal status of this entity. If you have questions about your shareholding, as we say elsewhere, they may be taken up here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.

Capital Gains Tax (CGT) Status: (updated at least quarterly)

To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. You will need to seek independent tax advice in relation to Capital Gains Tax or other tax matters but any other enquiries relating to your shareholding in the company should be followed up via our online form here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.

Updates, corrections, disagreements please email to admin@delisted.com.au

Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.

Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.

Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.

CHEMGENEX PHARMACEUTICALS LTD(CXS)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

	FROM	TO
AGT BIOSCIENCES LIMITED	24/03/2003	29/06/2004
AUTOGEN LIMITED	14/05/1999	24/03/2003
AUSTRALIA WIDE INDUSTRIES LIMITED	05/06/1986	14/05/1999
KINGSWAY GROUP LIMITED	01/08/1964	05/06/1986
N AND B FINANCE AND DEVELOPMENT CORPORATION LIMITED		01/08/1964

Shareholder links

Our website ranking of CXS:

(1 out of 5)

COMPANY WEBSITE:

CXS website

CXS directors

REGISTRY:

Level 21, 10 Eagle Street Brisbane QLD 4000

Tel : +61 7 3320 2200 or 1300 554 474
Fax : +61 2 9287 0303
RegistryWebsite RegistryEmail

Company details

Address: C/- LBW Chartered Accountants, 35 Gordon Avenue, Geelong West. Victoria 3218
Tel: +61 3 5223 9900 Fax: +61 3 5229 0100

Date first listed: 10/07/1986
Company Secretary:
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Pharmaceutical company developing therapeutics in the areas of oncology and hematology

News & Events

Expand this box to read and print

many shareholders in this company have unclaimed money due to them - deListed provides a tracing service for a small administration fee that identifies where people can find unclaimed monies arising from compulsory acquisitions and also from dividend distributions, super contributions, inoperative bank, building society or credit union accounts, bequests and other sources - please click here for access to our Lost shares, Lost money?? service	31/03/2022
delisted following completion of the takeover offer made by Cephalon Inc.	22/07/2011
we understand Cephalon was successful with off-market takeover offer of $0.70 cash per share and $0.02 cash per listed option	22/07/2011
Cephalon CXS Holdings Ltd bought 9,113,676 ChemGenex Pharmaceuticals Ltd shares between July 12 and 15, 2011 via takeover offer, increasing from 304,445,194 shares (97.09%) to 313,558,870 shares (100%)	21/07/2011
Cephalon CXS Holdings Ltd bought 12,198,508 ChemGenex Pharmaceuticals Ltd shares between June 15 and July 9, 2011 via takeover offer, increasing from 292,246,686 shares (93.20%) to 304,445,194 shares (97.09%)	12/07/2011
the securities of ChemGenex Pharmaceuticals Limited (the "Company") will be suspended from quotation at the close of trading on Tuesday, 21 June 2011 in accordance with listing rule 17.4, following the issue by Cephalon Inc. of compulsory acquisition notices	21/06/2011
shares reinstated to quotation	09/04/2009
the securities of ChemGenex Pharmaceuticals Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement by the Company	08/04/2009
we understand that on or about this date the company made an in specie distribution of 1 share in Autogen Research Pty Ltd for every 5 shares in the company	17/12/2007
we understand that on or about this date the company demerged Autogen (subsequently renamed Verva Pharmaceuticals Ltd)	15/11/2007
shares reinstated to quotation following receipt of an announcement providing details of the Company's completed capital raising	08/05/2006
advises of the intended offer of 35m ordinary shares by placement to selected sophisticated or professional investors	04/05/2006
securities suspended from quotation at the request of the company pending the release of an announcement	03/05/2006
name changed from AGT Biosciences Limited	29/06/2004

many shareholders in this company have unclaimed money due to them - deListed provides a tracing service for a small administration fee that identifies where people can find unclaimed monies arising from compulsory acquisitions and also from dividend distributions, super contributions, inoperative bank, building society or credit union accounts, bequests and other sources - please click here for access to our Lost shares, Lost money?? service	31/03/2022
delisted following completion of the takeover offer made by Cephalon Inc.	22/07/2011
we understand Cephalon was successful with off-market takeover offer of $0.70 cash per share and $0.02 cash per listed option	22/07/2011
Cephalon CXS Holdings Ltd bought 9,113,676 ChemGenex Pharmaceuticals Ltd shares between July 12 and 15, 2011 via takeover offer, increasing from 304,445,194 shares (97.09%) to 313,558,870 shares (100%)	21/07/2011
Cephalon CXS Holdings Ltd bought 12,198,508 ChemGenex Pharmaceuticals Ltd shares between June 15 and July 9, 2011 via takeover offer, increasing from 292,246,686 shares (93.20%) to 304,445,194 shares (97.09%)	12/07/2011
the securities of ChemGenex Pharmaceuticals Limited (the "Company") will be suspended from quotation at the close of trading on Tuesday, 21 June 2011 in accordance with listing rule 17.4, following the issue by Cephalon Inc. of compulsory acquisition notices	21/06/2011
shares reinstated to quotation	09/04/2009
the securities of ChemGenex Pharmaceuticals Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement by the Company	08/04/2009
we understand that on or about this date the company made an in specie distribution of 1 share in Autogen Research Pty Ltd for every 5 shares in the company	17/12/2007
we understand that on or about this date the company demerged Autogen (subsequently renamed Verva Pharmaceuticals Ltd)	15/11/2007
shares reinstated to quotation following receipt of an announcement providing details of the Company's completed capital raising	08/05/2006
advises of the intended offer of 35m ordinary shares by placement to selected sophisticated or professional investors	04/05/2006
securities suspended from quotation at the request of the company pending the release of an announcement	03/05/2006
name changed from AGT Biosciences Limited	29/06/2004

Your browser may reflect a date of printing in American format.

ASX Announcements (courtesy of ASX)

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

Company Updates

Post your comments here

Please read our Terms before posting comments.

Click here for free access to this company's:
ASX, Legal & CGT Status

Directors' on-market share transactions (last 5)

Click here for the last 20 transactions all companies

Directors & Executives (current)

NAME	TITLE	DATE OF APPT
James Campbell	CFO, COO
Tony Johnson	Director
Kevin Buchi	Director
Ron Kal	Director, Company Secretary
Wilco Groenhuysen	Director

Date of first appointment, title may have changed.

Directors & Executives (former)

NAME	TITLE	DATE OF APPOINTMENT	DATE OF RESIGNATION

Date of first appointment, title may have changed.